
DLF sells all 416 homes for over ₹2,300 crore in new Mumbai project Westpark
DLF Home Developers Ltd, a subsidiary of DLF Ltd, India's most valued real estate company, said it sold all 416 units, including apartments and penthouses, in the first phase of The Westpark project in suburban Mumbai's Andheri (west) locality. The sale kicked off last week.
Although DLF launched the project with two 37-storey towers initially, high demand prompted it to add two more towers. DLF is developing the project with New Delhi-based Trident Realty.
The developer sold the entire inventory within a week at an average price of ₹ 42,500 per square foot. Non-resident Indians accounted for about 20% of the sales. Three of the five penthouses were sold for ₹ 35 crore each, at about ₹ 70,000 per sq. ft.
'Mumbai projects usually sell at a staggered pace. We are overwhelmed by the demand for our project and the sales,' Aakash Ohri, joint managing director and chief business officer of DLF Home Developers, told Mint in an interview. 'The Mumbai launch was important for DLF, and this gives us confidence to do more in the city.'
The Westpark project marks DLF's return to Mumbai after exiting the property market there many years ago due to a sector slowdown.
'Mumbai is a key part of our national growth strategy. In Mumbai, customers liked the product offering including the amenities, followed by the brand value. Given the way we have entered the Mumbai market, we are here to stay,' Ohri added.
The Mumbai project follows similar swift sales in Gurugram – DLF Privana West and Privana South, which collectively raked in ₹ 12,800 crore last year, and its super-luxury project The Dahlias, which clocked about ₹ 13,744 crore of sales bookings in FY25.
The next big project from the DLF stable will be in Goa, in the current July-September quarter. The second phase of The Dahlias in Gurugram will be launched in the January-March quarter, Ohri said.
DLF was the second highest-selling developer in FY25, after Godrej Properties Ltd. The company reported record sales bookings of ₹ 21,223 crore in FY25, up 44% from ₹ 14,778 crore the previous year. It has projected sales of ₹ 20,000-22,000 crore in FY26, banking on a pipeline that includes the next phase of The Dahlias, and the Mumbai and Goa launches.
DLF has already achieved about half of its targeted sales for FY26 in the June-ended quarter. The company clocked ₹ 11,000 crore from bookings in Privana North, having sold the entire project inventory within a week of launch, it said in June.
Mumbai recorded 75,672 property registrations in the six months ended 30 June, up 4% from 72,491 in the corresponding period last year, Anarock Property Consultants said, citing data from the Inspector General of Registration.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hindu
2 hours ago
- The Hindu
Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety
After deploying robots to clean sewer lines in some city zones, Chennai Metrowater is now piloting the use of robotic technology in sewage pumping stations in Thiruvanmiyur. The initiative aims to enhance operational safety and efficiency by minimising manual intervention. The water agency has already added Bandicoot Mobility, a robot that cleans maintenance holes of the sewer network, to remove clogged waste in sewer lines in zone 6 ( 9 (Teynampet) and 13 (Adyar). With robotic devices, which were developed by Genrobotics, a Kerala-based startup, helping to reduce clogging of lines for a year now, the water agency is exploring other innovative technologies to improve maintenance of sewer infrastructure. Officials of the Metrowater said an advanced robot with remote control unit and cameras, Wilboar, is being used to clean the sewage wells in Thiruvanmiyur sewage pumping station on a pilot basis. The robotic unit developed by Genrobotics is lowered into the wells that have a depth of up to 10 metre to remove the silt. With high-pressure water jets and grinders, the device grinds accumulated sludge into finer particles and clears them. This would eliminate the challenges in the use of conventional processes, improve efficiency of cleaning sewer wells and reduce complaints of sewage overflow in the pipelines. The Thiruvanmiyur sewage pumping station has a capacity to handle 15 million litres of sewage a day. Such robotic devices are already in use at Nellore, Andhra Pradesh and Thiruvananthapuram, Kerala, said officials. There are 375 sewage pumping stations in the city. Such robotic devices would be deployed in sewer well cleaning operations in other pumping stations following the success of the trial implementation. Rao, president, Chennai Metropolitan Water Supply and Sewerage Board Labourers Union, said it was a welcome initiative to ensure workers' safety and reduce manual intervention. Such efforts must be expanded to densely populated urban spaces and monitored for regular maintenance. Workers hired for sewer network maintenance should be redeployed to other roles. Nearly 2,850 labourers have been hired for sewer and water network maintenance in Chennai.


Economic Times
2 hours ago
- Economic Times
Logistics played key role in Operation Sindoor success, says Rajnath Singh
Synopsis Defence Minister Rajnath Singh lauded Indian agencies for their seamless logistics management during Operation Sindoor, emphasizing its crucial role in the operation's success. He highlighted that modern warfare relies not only on weaponry but also on the timely delivery of resources. Seamless logistics management by Indian agencies-from mobilisation of the armed forces to delivering equipment at the right time and place-was a deciding factor in the success of Operation Sindoor, defence minister Rajnath Singh said on Sunday. ADVERTISEMENT In a virtual address at the convocation ceremony of Vadodara-based Gati Shakti Vishwavidyalaya (GSV), the minister said in the current era, wars are not just won by guns and bullets but by time-bound delivery of material, highlighting Op Sindoor as an example of excellent logistics management. "Whether it's soldiers fighting on the border or personnel engaged in disaster management, without coordination or proper management of resources, even the strongest of intentions weaken. Logistics is the power that transforms chaos into control. Power is measured not only by weapons, but also by timely resource management. Be it war, disaster or global pandemic, the nation which keeps its logistics chain strong is the most stable, secure and capable," he said. (You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online. NEXT STORY


Economic Times
2 hours ago
- Economic Times
Cheaper cancer care therapy earns big bucks for pharma company
India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow challenges. ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore. Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018. ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India. In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion." Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.